Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: BHVN) | Delayed: 14.58 +0.13 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.45 | 52 Week High | $ | |||
| Open | $14.44 | 52 Week Low | $ | |||
| Day High | $14.60 | P/E | N/A | |||
| Day Low | $14.13 | EPS | $ | |||
| Volume | 234,401 | |||||
